Rob Lowe Partners With Eli Lilly to Tackle Low Clinical Trial Participation
Summary
Actor Rob Lowe has partnered with pharmaceutical company Eli Lilly to encourage more cancer patients to join clinical trials. Lowe is motivated by personal experiences with cancer in his family and wants to correct misunderstandings about clinical trials. He believes trials provide patients with better care and supports raising awareness about them.Key Facts
- Only about 7% of U.S. cancer patients join clinical trials.
- Rob Lowe has partnered with Eli Lilly to boost participation in clinical trials.
- Lowe's motivation includes family experiences with cancer.
- Some people wrongly think clinical trials are only for very sick patients.
- Lowe explains patients get excellent care even if they receive a placebo.
- Research suggests clinical trial participants receive better care.
- Lowe has spoken at events to raise awareness, like the HLTH conference.
- Other celebrities are also using their platforms to raise awareness for health issues.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.